The Path to Laboratory Transformation: From Scientific Work to Scalable Capability



11th February 2027 | 9:30am EST / 6:30am PST / 2:30pm GMT / 3:30pm CET | Leonard Blackwell, Ph.D. Senior Consultant, Lab of the Future & Robotics at Hyperplane LLC Saly Romero-Torres, Ph.D. Owner, Hyperplane LLC, Followed by Dr. Cenk Ündey, PhD, Global iCMC Digital Transformation Program Business Lead at Sanofi |BOOK FREE SEAT FOR THIS WEBINAR

Laboratory transformation promises greater productivity, better data, and more effective use of automation and digital technology, yet many organizations struggle to move beyond isolated improvements. Technology alone does not transform a laboratory. Lasting change begins with understanding how scientific work is performed and then building the capabilities, systems, and operating models needed to improve it.

This webinar presents a practical framework for laboratory transformation developed through more than two decades of experience in scientific automation, analytical development, digital laboratory initiatives, and organizational change. The framework begins with the science and the work, then progresses through standardization, reusable capability, connected systems, and people-led change.

Drawing on examples ranging from assay automation to organization-wide scientific capabilities, the presentation will show how transformation can evolve from solving an immediate scientific problem to creating approaches that are trusted, reusable, and scalable. As these capabilities mature, they begin to reshape how work is performed, supported, and connected across the laboratory.

Rather than treating transformation as a distant end state, the webinar will show how organizations can define where they want to go and move toward that vision through successive stages of meaningful impact, with each step improving today’s laboratory while building the capability required for tomorrow.

Presented by Leonard Blackwell, Ph.D. Senior Consultant, Lab of the Future & Robotics at Hyperplane LLC

Leonard Blackwell, Ph.D., is a scientist, laboratory transformation leader, and consultant with more than 20 years of experience across pharmaceutical research and development, biotechnology, automation, and digital laboratory strategy. His career has focused on improving how scientific work is executed by bringing together workflows, laboratory technologies, automation, digital systems, and scientific information.

During his tenure at Biogen, Leonard built and led a multidisciplinary Strategic Analytics team supporting Analytical Development. His group developed and deployed automation, informatics, data solutions, and emerging technologies that improved scientific productivity, data integrity, and organizational capability across laboratory operations.

Leonard has also held scientific and leadership roles at Pfizer, Wyeth, Amphora Discovery, and Duke University, with experience spanning vaccines, biologics, assay development, high-throughput operations, laboratory robotics, and scientific data systems.

Today, as Senior Consultant, Lab of the Future & Robotics at Hyperplane LLC, Leonard helps organizations assess laboratory operations, identify opportunities for transformation, and develop practical strategies that connect people, processes, technology, and information. He holds a Ph.D. in Biochemistry from New York University.

and Saly Romero-Torres, Ph.D. Owner, Hyperplane LLC

Saly Romero-Torres, Ph.D. is an experienced senior leader with over 20 years of expertise in advanced manufacturing and strategy. She has a diverse track record spanning digital transformation, operations, global network strategy, strategic planning, financial management, quality systems, regulatory compliance, data analytics, artificial intelligence, workforce development, and operational excellence.

She is a proud former Board Member of the Chemical Sciences and Technologies Board at the U.S. National Academies, recognized for shaping science and technology policy at the national level. Saly has authored and co-authored more than 20 publications in advanced manufacturing.

She is the founder and owner of Hyperplane LLC, a consulting firm dedicated to helping customers develop and operationalize their digital and AI strategies.

iCMC Digital Transformation: A journey Towards Enabling Smart Process Development and Manufacturing

Sanofi’s multiyear iCMC Digital Transformation program now spans more than 2,500 users, about 100 labs and 20 sites. This talk traces its journey from data capture via wet lab digital ecosystem including eLN/LES and automated data acquisition during experiment. It highlights the data foundation required for AI at scale, end-to-end workflows, and hybrid digital twins that cut process characterization from months to days and support commercial batch monitoring. We also highlight the importance of the change management and adoption. The talk closes with lessons learned and the path toward autonomous, self-driving bioprocesses.

Presented by Dr. Cenk Ündey, PhD, Global iCMC Digital Transformation Program Business Lead at Sanofi

Dr. Undey is currently leading the Global iCMC Digital Transformation Program at Sanofi that is spanning 2500+ users, about 100 labs across 20 sites and global business units in Pharma and Vaccine R&D and MSAT. Previously, he has led the Pharmaceutical Technical Development Data & Digital organization in Roche. Before that, he led the Operations Advanced Analytics team, and many years in Process Development roles at Amgen. His group helped improve end-to-end Operations for Reliability, Efficiency, Agility and Differentiation using digital capabilities including Industry 4.0, machine learning, and digital twins. He has co-authored two books, published in the areas of process systems engineering, PAT, artificial intelligence, process monitoring, control, biotechnology and bioengineering. He has received his B.Sc., M.Sc. and Ph.D. degrees all in Chemical Engineering from Istanbul University, Türkiye. He holds an Executive MBA degree from the University of California, Los Angeles. Dr. Undey is based in Boston, MA, USA.

Followed by a live question and answer session


We will not sell your information to a third party. See our Privacy Policy

Biopharma Webinars